Results 91 to 100 of about 24,028 (137)

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. [PDF]

open access: yesOphthalmology, 2016
Sharma S   +9 more
europepmc   +1 more source

DNA-mediated dimerization on a compact sequence signature controls enhancer engagement and regulation by FOXA1. [PDF]

open access: yesNucleic Acids Res, 2018
Wang X   +8 more
europepmc   +1 more source

Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. [PDF]

open access: yesOphthalmology, 2016
Shah N   +9 more
europepmc   +1 more source

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). [PDF]

open access: yesOphthalmology, 2016
Daniel E   +7 more
europepmc   +1 more source

Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset. [PDF]

open access: yesEur J Immunol, 2016
Cabrera SM   +9 more
europepmc   +1 more source

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials. [PDF]

open access: yesOphthalmology, 2015
Willoughby AS   +8 more
europepmc   +1 more source

Collaborative Visual Analytics: A Health Analytics Approach to Injury Prevention. [PDF]

open access: yesInt J Environ Res Public Health, 2017
Al-Hajj S, Fisher B, Smith J, Pike I.
europepmc   +1 more source

Home - About - Disclaimer - Privacy